Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm(2)) in alzheimer's disease - Cummings, Jeffrey L.; Frölich, Lutz (Dementia and geriatric cognitive disorders, 2012)